carvedilol has been researched along with oxazolidin-2-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, K; Kai, S; Matsukawa, S; Seo, H; Suzuki, K | 1 |
1 other study(ies) available for carvedilol and oxazolidin-2-one
Article | Year |
---|---|
Activation of the β-adrenergic receptor exacerbates lipopolysaccharide-induced wasting of skeletal muscle cells by increasing interleukin-6 production.
Topics: Animals; Carvedilol; CCAAT-Enhancer-Binding Protein-delta; Epinephrine; Gene Expression Regulation; Humans; Interleukin-6; Isoproterenol; Lipopolysaccharides; Mice; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Myoblasts; NF-kappa B; Nitriles; Norepinephrine; Oxazolidinones; Receptors, Adrenergic, beta; SKP Cullin F-Box Protein Ligases; STAT3 Transcription Factor; Sulfones | 2021 |